Neogi Ujjwal, Prarthana B S, Gupta Soham, D'souza George, De Costa Ayesha, Kuttiatt Vijesh Sreedhar, Arumugam Karthika, Shet Anita
St. John's National Academy of Health Sciences, Bangalore, India.
AIDS Res Hum Retroviruses. 2010 Oct;26(10):1097-101. doi: 10.1089/aid.2010.0092. Epub 2010 Sep 13.
Although India has a large burden of HIV infection, good access to first-line antiretroviral therapy is widely available. However, understanding HIV resistance-associated mutations and polymorphisms is critical for continued success. The RT region of the HIV-1 pol gene was studied among 21 ART-naive HIV-1-infected individuals from South India. In addition, 421 published Indian HIV-1 subtype C sequences were analyzed for time trends in polymorphism frequency. Among primary isolates, all HIV-1 isolates were subtype C, and drug-resistant mutations were identified among two (9.56%) subjects. Mutations included E138A (etravirine resistance associated) and L210LS (thymidine analog mutation). The overall frequency of specific polymorphisms was similar to frequencies reported from different regions of India. Novel mutations were observed at positions Q23P/H and A129AG among isolates from our clinical cohort. Over a span of 10 years, the median polymorphism frequency among ART-naive subjects has remained unchanged, suggesting the slow evolution of HIV-1 subtype C in India.
尽管印度的艾滋病毒感染负担沉重,但一线抗逆转录病毒疗法的可及性广泛。然而,了解与艾滋病毒耐药相关的突变和多态性对于持续取得成功至关重要。在来自印度南部的21名未接受过抗逆转录病毒治疗(ART)的艾滋病毒-1感染者中,对艾滋病毒-1 pol基因的逆转录酶(RT)区域进行了研究。此外,对421条已发表的印度艾滋病毒-1 C亚型序列分析了多态性频率的时间趋势。在原始分离株中,所有艾滋病毒-1分离株均为C亚型,在两名(9.56%)受试者中鉴定出耐药突变。突变包括E138A(与依曲韦林耐药相关)和L210LS(胸苷类似物突变)。特定多态性的总体频率与印度不同地区报告的频率相似。在我们临床队列的分离株中,在Q23P/H和A129AG位点观察到新的突变。在10年的时间里,未接受过抗逆转录病毒治疗的受试者中的多态性频率中位数保持不变,这表明印度艾滋病毒-1 C亚型的进化缓慢。